News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alcon Laboratories, Inc. (ACL) Directors Say Novartis Corporation (NVS) Bid Grossly Inadequate


1/20/2010 6:25:37 AM

Bookmark and Share

Reuters -- Novartis AG's offer to buy out minority shareholders in Alcon Inc is "grossly inadequate", independent directors of the eyecare group said on Wednesday, setting the stage for a prolonged battle.

Read at Reuters
Read at The Street.com
Read at Wall Street Journal
Read at Market Watch

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES